Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

FDA advisory committee recommends additional analyses of Vitrase data

March 20, 2003

No Comments

Clinical testing of ISV-403 scheduled to begin in second quarter

March 11, 2003

No Comments

InSite Vision receives patent allowance for azalides in topical ocular infection treatment

March 4, 2003

No Comments

Novartis discloses novel IOP-lowering agents

Feb. 28, 2003

No Comments

Retisert filing for posterior uveitis now scheduled for mid-2004

Feb. 26, 2003

No Comments

Controlled delivery of EYE-001 encapsulated in PLGA microspheres

Feb. 7, 2003

No Comments

SBIR grant supports MitoKor efforts in glaucoma

Feb. 5, 2003

No Comments

NDA filing planned for PDT therapy for AMD

Feb. 4, 2003

No Comments

T-588 prevents retinal ganglion cell death in rats with elevated IOP

Jan. 29, 2003

No Comments

FDA advisory committee to review Vitrase NDA

Jan. 29, 2003

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Ocular
RSS

FDA advisory committee recommends additional analyses of Vitrase data

Clinical testing of ISV-403 scheduled to begin in second quarter

InSite Vision receives patent allowance for azalides in topical ocular infection treatment

Novartis discloses novel IOP-lowering agents

Retisert filing for posterior uveitis now scheduled for mid-2004

Controlled delivery of EYE-001 encapsulated in PLGA microspheres

SBIR grant supports MitoKor efforts in glaucoma

NDA filing planned for PDT therapy for AMD

T-588 prevents retinal ganglion cell death in rats with elevated IOP

FDA advisory committee to review Vitrase NDA

Today's news in brief

Today's news in brief

Second insulin receptor offers new therapeutic avenues

Mechanism underlying so-called idiopathic autism inception unveiled

Keros stock wilts as it halts two dosing arms in hypertension study

Ocular RSS

Ocular
RSS